Form 8-K - Current report:
SEC Accession No. 0000950170-24-110890
Filing Date
2024-10-01
Accepted
2024-10-01 16:40:59
Documents
11
Period of Report
2024-09-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K tsbx-20240927.htm   iXBRL 8-K 43008
  Complete submission text file 0000950170-24-110890.txt   161444

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tsbx-20240927.xsd EX-101.SCH 26014
13 EXTRACTED XBRL INSTANCE DOCUMENT tsbx-20240927_htm.xml XML 4923
Mailing Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

EIN.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41747 | Film No.: 241343942
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)